CA Stock MarketDetailed Quotes

AION Aion Therapeutic Inc

Watchlist
  • 0.005
  • -0.005-50.00%
15min DelayMarket Closed Apr 24 09:51 ET
2.49MMarket Cap-0.26P/E (TTM)

Aion Therapeutic Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jan 31, 2025
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
(Q2)Oct 31, 2023
(Q1)Jul 31, 2023
(FY)Apr 30, 2023
(Q4)Apr 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-117.97%-43.71K
-238.40%-148.27K
-131.31%-544.93K
-1,941.32%-845.05K
-633.69%-808.88K
303.08%243.24K
-650.30%-43.82K
-190.31%-235.59K
96.93%-41.4K
1,205.36%151.57K
Net income from continuing operations
22.62%-292.46K
-221.36%-582.81K
-12.85%-370.81K
-2,349.64%-6.29M
-2,487.43%-5.4M
-75.21%-377.95K
-44.42%-181.36K
-212.02%-328.58K
93.28%-256.66K
87.11%-208.67K
Operating gains losses
----
----
----
----
----
----
----
----
---563.3K
--135.19K
Depreciation and amortization
151.95%37.73K
--28.59K
--28.68K
143.37%42.11K
21,434.13%27.13K
156.56%14.97K
--0
--0
-73.50%17.3K
-92.19%126
Asset impairment expenditure
----
----
----
916.04%2.01M
----
----
----
----
-124.68%-246.84K
---135.19K
Unrealized gains and losses of investment securities
----
----
----
-88.09%12.96K
----
----
----
----
--108.81K
----
Other non cashItems
235.82%160.37K
117.91%63.73K
52.41%52.5K
1,960.19%3.02M
9,259.54%2.91M
13.84%47.75K
-24.23%29.24K
-1.85%34.45K
110.70%146.76K
7.95%31.11K
Change In working capital
-90.93%50.66K
216.00%342.22K
-536.06%-255.3K
-53.59%349.26K
-270.78%-376.05K
202.84%558.47K
21.48%108.3K
-77.38%58.55K
-43.70%752.53K
-63.30%220.19K
-Change in receivables
116.79%6.95K
-754.61%-99.93K
-111.03%-17.39K
401.20%165.34K
276.45%33.76K
-523.44%-41.37K
226.02%15.27K
1,027.01%157.68K
29.16%-54.89K
-586.30%-19.13K
-Change in inventory
436.19%175.45K
---55.77K
---124.3K
---76.89K
---24.71K
---52.19K
--0
--0
--0
--0
-Change in prepaid assets
--42.58K
1,342.74%21.75K
---388.27K
-326.54%-17.34K
---15.59K
--0
---1.75K
--0
-96.35%7.66K
--0
-Change in payables and accrued expense
-74.74%160.04K
-167.85%-76.88K
377.09%274.68K
-65.22%278.16K
-254.40%-369.52K
290.73%633.5K
11.89%113.31K
-133.37%-99.13K
-32.61%799.77K
-43.66%239.33K
-Change in other working capital
---334.35K
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-117.97%-43.71K
-238.40%-148.27K
-131.31%-544.93K
-1,941.32%-845.05K
-633.69%-808.88K
303.08%243.24K
-650.30%-43.82K
-190.31%-235.59K
96.93%-41.4K
1,205.36%151.57K
Investing cash flow
Cash flow from continuing investing activities
0
0
0
-314.09%-289.42K
0
-117.28%-23.36K
-201.28K
-64.78K
135.19K
0
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
--135.19K
--0
Net other investing changes
----
----
----
---289.42K
--0
---23.36K
---201.28K
---64.78K
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
-314.09%-289.42K
--0
-117.28%-23.36K
---201.28K
---64.78K
--135.19K
--0
Financing cash flow
Cash flow from continuing financing activities
386.84%237.13K
-80.14%76.96K
267.13%569.05K
586.17%1.12M
61,405.93%528.95K
139.51%48.71K
124.18%387.5K
37.37%155K
-86.37%163.25K
-98.80%860
Net issuance payments of debt
941.69%237.13K
---165.04K
--369.05K
-96.77%2.05K
-2,509.19%-20.72K
118.46%22.76K
--0
--0
-43.07%63.25K
-98.80%860
Net common stock issuance
--0
-55.39%242K
--200K
--542.5K
--0
--0
--542.5K
--0
--0
--0
Net other financing activities
----
----
----
475.61%575.61K
--549.67K
----
----
--155K
487.75%100K
--0
Cash from discontinued financing activities
Financing cash flow
386.84%237.13K
-80.14%76.96K
267.13%569.05K
586.17%1.12M
61,405.93%528.95K
139.51%48.71K
124.18%387.5K
37.37%155K
-86.37%163.25K
-98.80%860
Net cash flow
Beginning cash position
10,018.25%93.7K
138.67%80.96K
20,238.10%68.34K
--336
--349.28K
-93.13%926
100.25%33.92K
--336
--0
--0
Current changes in cash
-27.99%193.42K
-150.07%-71.31K
116.59%24.12K
-105.57%-14.31K
-283.65%-279.93K
348.97%268.58K
-21.24%142.4K
-558.84%-145.36K
271.85%257.04K
83.40%152.43K
Effect of exchange rate changes
-442.59%-273.29K
147.92%84.05K
-106.43%-11.5K
132.06%82.31K
99.33%-1.02K
-15.50%79.77K
4.82%-175.4K
1,313.93%178.95K
-184.40%-256.7K
-79.00%-152.09K
End cash Position
-96.04%13.82K
10,018.25%93.7K
138.67%80.96K
20,238.10%68.34K
20,238.10%68.34K
--349.28K
-93.13%926
100.25%33.92K
--336
--336
Free cash from
-117.97%-43.71K
-238.40%-148.27K
-131.31%-544.93K
-1,941.32%-845.05K
-633.69%-808.88K
303.08%243.24K
-650.30%-43.82K
-190.31%-235.59K
96.93%-41.4K
1,205.36%151.57K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jan 31, 2025(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024(Q2)Oct 31, 2023(Q1)Jul 31, 2023(FY)Apr 30, 2023(Q4)Apr 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -117.97%-43.71K-238.40%-148.27K-131.31%-544.93K-1,941.32%-845.05K-633.69%-808.88K303.08%243.24K-650.30%-43.82K-190.31%-235.59K96.93%-41.4K1,205.36%151.57K
Net income from continuing operations 22.62%-292.46K-221.36%-582.81K-12.85%-370.81K-2,349.64%-6.29M-2,487.43%-5.4M-75.21%-377.95K-44.42%-181.36K-212.02%-328.58K93.28%-256.66K87.11%-208.67K
Operating gains losses -----------------------------------563.3K--135.19K
Depreciation and amortization 151.95%37.73K--28.59K--28.68K143.37%42.11K21,434.13%27.13K156.56%14.97K--0--0-73.50%17.3K-92.19%126
Asset impairment expenditure ------------916.04%2.01M-----------------124.68%-246.84K---135.19K
Unrealized gains and losses of investment securities -------------88.09%12.96K------------------108.81K----
Other non cashItems 235.82%160.37K117.91%63.73K52.41%52.5K1,960.19%3.02M9,259.54%2.91M13.84%47.75K-24.23%29.24K-1.85%34.45K110.70%146.76K7.95%31.11K
Change In working capital -90.93%50.66K216.00%342.22K-536.06%-255.3K-53.59%349.26K-270.78%-376.05K202.84%558.47K21.48%108.3K-77.38%58.55K-43.70%752.53K-63.30%220.19K
-Change in receivables 116.79%6.95K-754.61%-99.93K-111.03%-17.39K401.20%165.34K276.45%33.76K-523.44%-41.37K226.02%15.27K1,027.01%157.68K29.16%-54.89K-586.30%-19.13K
-Change in inventory 436.19%175.45K---55.77K---124.3K---76.89K---24.71K---52.19K--0--0--0--0
-Change in prepaid assets --42.58K1,342.74%21.75K---388.27K-326.54%-17.34K---15.59K--0---1.75K--0-96.35%7.66K--0
-Change in payables and accrued expense -74.74%160.04K-167.85%-76.88K377.09%274.68K-65.22%278.16K-254.40%-369.52K290.73%633.5K11.89%113.31K-133.37%-99.13K-32.61%799.77K-43.66%239.33K
-Change in other working capital ---334.35K------------------------------------
Cash from discontinued investing activities
Operating cash flow -117.97%-43.71K-238.40%-148.27K-131.31%-544.93K-1,941.32%-845.05K-633.69%-808.88K303.08%243.24K-650.30%-43.82K-190.31%-235.59K96.93%-41.4K1,205.36%151.57K
Investing cash flow
Cash flow from continuing investing activities 000-314.09%-289.42K0-117.28%-23.36K-201.28K-64.78K135.19K0
Net PPE purchase and sale --------------0------------------135.19K--0
Net other investing changes ---------------289.42K--0---23.36K---201.28K---64.78K--------
Cash from discontinued investing activities
Investing cash flow --0--0--0-314.09%-289.42K--0-117.28%-23.36K---201.28K---64.78K--135.19K--0
Financing cash flow
Cash flow from continuing financing activities 386.84%237.13K-80.14%76.96K267.13%569.05K586.17%1.12M61,405.93%528.95K139.51%48.71K124.18%387.5K37.37%155K-86.37%163.25K-98.80%860
Net issuance payments of debt 941.69%237.13K---165.04K--369.05K-96.77%2.05K-2,509.19%-20.72K118.46%22.76K--0--0-43.07%63.25K-98.80%860
Net common stock issuance --0-55.39%242K--200K--542.5K--0--0--542.5K--0--0--0
Net other financing activities ------------475.61%575.61K--549.67K----------155K487.75%100K--0
Cash from discontinued financing activities
Financing cash flow 386.84%237.13K-80.14%76.96K267.13%569.05K586.17%1.12M61,405.93%528.95K139.51%48.71K124.18%387.5K37.37%155K-86.37%163.25K-98.80%860
Net cash flow
Beginning cash position 10,018.25%93.7K138.67%80.96K20,238.10%68.34K--336--349.28K-93.13%926100.25%33.92K--336--0--0
Current changes in cash -27.99%193.42K-150.07%-71.31K116.59%24.12K-105.57%-14.31K-283.65%-279.93K348.97%268.58K-21.24%142.4K-558.84%-145.36K271.85%257.04K83.40%152.43K
Effect of exchange rate changes -442.59%-273.29K147.92%84.05K-106.43%-11.5K132.06%82.31K99.33%-1.02K-15.50%79.77K4.82%-175.4K1,313.93%178.95K-184.40%-256.7K-79.00%-152.09K
End cash Position -96.04%13.82K10,018.25%93.7K138.67%80.96K20,238.10%68.34K20,238.10%68.34K--349.28K-93.13%926100.25%33.92K--336--336
Free cash from -117.97%-43.71K-238.40%-148.27K-131.31%-544.93K-1,941.32%-845.05K-633.69%-808.88K303.08%243.24K-650.30%-43.82K-190.31%-235.59K96.93%-41.4K1,205.36%151.57K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More